Literature DB >> 11029793

A case of breast cancer diagnosed by inguinal lymph node metastasis.

M Baba1, M Tatsuta, A Miya, H Ishida, S Masutani, T Kawasaki, T Satomi, J Hanai, F Kimura.   

Abstract

We describe a case of a 58-year-old woman with right inguinal lymph node swelling and a T1 tumor in the right breast. She was referred with an 18-month history of the former complaint and a six-month history of the latter. Excisional biopsy of the inguinal lymph node revealed breast cancer metastasis. Radiographical examination showed no metastases to the lungs, liver or bone. Modified radical mastectomy was performed. Histological examination revealed solid tubular carcinoma, PT2, PM (axillary lymph node metastases 4/16), stage IV. Estrogen and progesterone receptors were negative. Three cycles of postoperative cyclophosphamide, adriamycin and 5-fluorouracil (CAF) chemotherapy were given, and the right inguinal area was irradiated with 40 Gy. The patient complained of swelling in both legs three years after surgery. Computed tomography revealed marked lymph node swellings in the pelvic cavity. She died six months later. Inguinal lymph node metastasis from breast cancer is very rare, although distant lymph node metastasis in the cervix occurs frequently. This case should help clarify how breast cancer metastasizes to distant lymph nodes.

Entities:  

Mesh:

Year:  2000        PMID: 11029793     DOI: 10.1007/bf02967453

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  2 in total

1.  A modeling platform for the lymphatic system.

Authors:  Javier Ruiz-Ramírez; Arturas Ziemys; Prashant Dogra; Mauro Ferrari
Journal:  J Theor Biol       Date:  2020-02-28       Impact factor: 2.691

Review 2.  Ovarian cancer initially presenting with isolated ipsilateral superficial inguinal lymph node metastasis: a case study and review of the literature.

Authors:  Xiao-Jun Yang; Fei-Yun Zheng; Yun-Sheng Xu; Rong-Ying Ou
Journal:  J Ovarian Res       Date:  2014-02-10       Impact factor: 4.234

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.